Graefes Arch Clin Exp Ophthalmol (2017) 255:1681–1682 DOI 10.1007/s00417-017-3686-x LETTER TO THE EDITOR Intracameral cefuroxime in the prevention of postoperative endophthalmitis 1 1,2 Louis W. Lim & Colin S. Tan Received: 29 March 2017 /Accepted: 24 April 2017 /Published online: 13 May 2017 Springer-Verlag Berlin Heidelberg 2017 Dear Editor, In the current study, patients seem to have had worse visual In a recent publication, Ng et al.  evaluated the efficacy and outcomes than those in other studies, despite coagulase- safety of intracameral cefuroxime following cataract surgery, negative staphylococcus being the dominant organism. Only and reported that the Buse of intracameral cefuroxime could one patient had visual acuity (VA) of better than 0.1, with three eyes requiring evisceration. In contrast, previous studies [3, 6, significantly reduce the rate of postoperative endophthalmitis.^ Many studies conducted among different populations have 7] have shown that up to 28.6% of patients were able to main- reported significant reductions in the rate of postoperative en- tain a final VA of 20/20 to 20/40. We are curious whether the dophthalmitis when intracameral antibiotics were introduced authors identified any particular reason for the visual out- [2–5]. The optimal choice of antibiotic, however, remains the comes. They
Graefe's Archive for Clinical and Experimental Ophthalmology – Springer Journals
Published: May 13, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera